36
Participants
Start Date
September 30, 2015
Primary Completion Date
December 31, 2015
Study Completion Date
May 31, 2016
Placebo
Patients in this arm will receive sub-cutaneous injections of placebo (same vehicle as for experimental arms, and same volume) for 5 consecutive days at the beginning of three consecutive months (a total of 15 injections, 5 per month for 3 months).
1.0 MIU IL-2 per day
Patients in this arm will receive sub-cutaneous injections corresponding to 1.0 MIU of IL-2 per injection for 5 consecutive days at the beginning of three consecutive months (a total of 15 injections, 5 per month for 3 months).
2.0 MIU IL-2 per day
Patients in this arm will receive sub-cutaneous injections corresponding to 2.0 MIU of IL-2 per injection for 5 consecutive days at the beginning of three consecutive months (a total of 15 injections, 5 per month for 3 months).
CHRU de Montpellier - Hôpital Gui de Chauliac, Montpellier
Centre Hospitalier Universitaire de Nīmes
OTHER